Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators, Bioorganic & Medicinal Chemistry Letters, vol.26, issue.21, pp.5139-5148, 2016. ,
DOI : 10.1016/j.bmcl.2016.09.065
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome, Cell Metabolism, vol.3, issue.6, pp.403-416, 2006. ,
DOI : 10.1016/j.cmet.2006.05.005
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, Journal of Clinical Investigation, vol.115, issue.5, pp.1343-1351, 2005. ,
DOI : 10.1172/JCI23621
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models, EBioMedicine, 2018. ,
DOI : 10.1016/j.ebiom.2018.04.009
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin, Nature Medicine, vol.261, issue.12, pp.1649-1654, 2013. ,
DOI : 10.1111/j.1749-6632.1959.tb44923.x
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation, Cell Metabolism, vol.26, issue.2, pp.394-406, 2017. ,
DOI : 10.1016/j.cmet.2017.07.009
AMPK: Sensing Glucose as well as Cellular Energy Status, Cell Metabolism, vol.27, issue.2, pp.299-313, 2018. ,
DOI : 10.1016/j.cmet.2017.10.009
Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy, Science, vol.277, issue.6350, pp.507-511, 2017. ,
DOI : 10.1016/j.cmet.2017.04.010
Treatment of nonalcoholic fatty liver disease: role of AMPK, American Journal of Physiology-Endocrinology and Metabolism, vol.309, issue.4, pp.730-740, 2016. ,
DOI : 10.1172/JCI13505